Integration of multiple signaling pathway activities resolves K-RAS/N-RAS mutation paradox in colon epithelial cell response to inflammatory cytokine stimulation
Open Access
- 1 January 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Integrative Biology
- Vol. 2 (4), 202-208
- https://doi.org/10.1039/b925935j
Abstract
Colon tumors frequently harbor mutation in K-RAS and/or N-RAS, members of a GTPase family operating as a central hub for multiple key signaling pathways. While these proteins are strongly homologous, they exhibit diverse downstream effects on cell behavior. Utilizing an isogenic panel of human colon carcinoma cells bearing oncogenic mutations in K-RAS and/or N-RAS, we observed that K-RAS and double mutants similarly yield elevated apoptosis in response to treatment with TNFα compared to N-RAS mutants. Regardless, and in surprising contrast, key phospho-protein signals were more similar between N-RAS and dual mutants. This apparent contradiction could not be explained by any of the key signals individually, but a multi-pathway model constructed from the single-mutant cell line data was able to predict the behavior of the dual-mutant cell line. This success arises from a quantitative integration of multiple pro-apoptotic (pIκBα, pERK2) and pro-survival (pJNK, pHSP27) signals in manner not easily discerned from intuitive inspection.Keywords
This publication has 19 references indexed in Scilit:
- A tumour gene's fatal flawsNature, 2009
- The role of inflammation in the pathogenesis of colorectal cancerCurrent Colorectal Cancer Reports, 2009
- Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colonNature Genetics, 2008
- Oncogenic K-RAS subverts the antiapoptotic role of N-RAS and alters modulation of the N-RAS: gelsolin complexOncogene, 2006
- Oncogenic Ras Promotes Butyrate-induced Apoptosis through Inhibition of Gelsolin ExpressionOnline Journal of Public Health Informatics, 2004
- RAS oncogenes: the first 30 yearsNature Reviews Cancer, 2003
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003
- Altered Growth of Human Colon Cancer Cell Lines Disrupted at Activated Ki- rasScience, 1993
- C-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinomaGastroenterology, 1990
- Detection of high incidence of K-ras oncogenes during human colon tumorigenesisNature, 1987